| Three Months Ended | ||||||||||||||||||||
| March 31, 2026 | March 31, 2025 | June 30, 2025 | September 30, 2025 | December 31, 2025 | ||||||||||||||||
| Net sales | ||||||||||||||||||||
| Building Automation | $ | 1,882 | $ | 1,692 | $ | 1,826 | $ | 1,878 | $ | 1,971 | ||||||||||
| Process Automation and Technology | 1,513 | 1,445 | 1,613 | 1,598 | 1,781 | |||||||||||||||
| Industrial Automation | 1,423 | 1,600 | 1,577 | 1,450 | 1,484 | |||||||||||||||
| Total Segment sales | $ | 4,818 | $ | 4,737 | $ | 5,016 | $ | 4,926 | $ | 5,236 | ||||||||||
Quantinuum2 | 5 | 19 | 2 | 3 | 6 | |||||||||||||||
| Total Net sales from continuing operations | $ | 4,823 | $ | 4,756 | $ | 5,018 | $ | 4,929 | $ | 5,242 | ||||||||||
Total Net sales from discontinued operations1 | $ | 4,320 | $ | 5,066 | $ | 5,334 | $ | 5,479 | $ | 4,862 | ||||||||||
| Segment profit | ||||||||||||||||||||
| Building Automation | $ | 496 | $ | 440 | $ | 479 | $ | 502 | $ | 532 | ||||||||||
| Process Automation and Technology | 359 | 313 | 386 | 389 | 454 | |||||||||||||||
| Industrial Automation | 240 | 231 | 257 | 216 | 192 | |||||||||||||||
Corporate2,3 | (151) | (191) | (218) | (241) | (234) | |||||||||||||||
| Total segment profit from continuing operations | $ | 944 | $ | 793 | $ | 904 | $ | 866 | $ | 944 | ||||||||||
Total segment profit from discontinued operations1 | $ | 1,248 | $ | 1,492 | $ | 1,511 | $ | 1,590 | $ | 1,095 | ||||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Effective the second quarter of 2026, Quantinuum Inc. (“Quantinuum”) no longer meets the definition of an operating segment, and sales and losses attributable to Quantinuum are excluded from Segment sales and Segment profit, respectively. | |||||||
| 3 | Corporate expenses historically allocated to the Aerospace Technologies and AM businesses and not eligible to be part of discontinued operations are included in Corporate. | |||||||
| Three Months Ended | ||||||||||||||
| March 31, 2024 | June 30, 2024 | September 30, 2024 | December 31, 2024 | |||||||||||
| Net sales | ||||||||||||||
| Building Automation | $ | 1,426 | $ | 1,571 | $ | 1,745 | $ | 1,798 | ||||||
| Process Automation and Technology | 1,352 | 1,408 | 1,478 | 1,681 | ||||||||||
| Industrial Automation | 1,709 | 1,702 | 1,683 | 1,704 | ||||||||||
| Total Segment sales | $ | 4,487 | $ | 4,681 | $ | 4,906 | $ | 5,183 | ||||||
| Quantinuum | 7 | 5 | 7 | 5 | ||||||||||
| Total Net sales from continuing operations | $ | 4,494 | $ | 4,686 | $ | 4,913 | $ | 5,188 | ||||||
Total Net sales from discontinued operations1 | $ | 4,611 | $ | 4,891 | $ | 4,815 | $ | 4,900 | ||||||
| Segment profit | ||||||||||||||
| Building Automation | $ | 350 | $ | 397 | $ | 452 | $ | 482 | ||||||
| Process Automation and Technology | 289 | 346 | 381 | 448 | ||||||||||
| Industrial Automation | 286 | 271 | 287 | 273 | ||||||||||
Corporate2,3 | (210) | (267) | (240) | (218) | ||||||||||
| Total segment profit from continuing operations | $ | 715 | $ | 747 | $ | 880 | $ | 985 | ||||||
Total segment profit from discontinued operations1 | $ | 1,410 | $ | 1,488 | $ | 1,452 | $ | 1,164 | ||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Effective the second quarter of 2026, Quantinuum Inc. (“Quantinuum”) no longer meets the definition of an operating segment, and sales and losses attributable to Quantinuum are excluded from Segment sales and Segment profit, respectively. | |||||||
| 3 | Corporate expenses historically allocated to the Aerospace Technologies and AM businesses and not eligible to be part of discontinued operations are included in Corporate. | |||||||
| Years Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net sales | |||||||||||
| Building Automation | $ | 7,367 | $ | 6,540 | |||||||
| Process Automation and Technology | 6,437 | 5,919 | |||||||||
| Industrial Automation | 6,111 | 6,798 | |||||||||
| Total Segment sales | $ | 19,915 | $ | 19,257 | |||||||
| Quantinuum | 30 | 24 | |||||||||
| Total Net sales from continuing operations | $ | 19,945 | $ | 19,281 | |||||||
Total Net sales from discontinued operations1 | $ | 20,741 | $ | 19,217 | |||||||
| Segment profit | |||||||||||
| Building Automation | $ | 1,953 | $ | 1,681 | |||||||
| Process Automation and Technology | 1,542 | 1,464 | |||||||||
| Industrial Automation | 896 | 1,117 | |||||||||
Corporate2,3 | (884) | (935) | |||||||||
| Total segment profit from continuing operations | $ | 3,507 | $ | 3,327 | |||||||
Total segment profit from discontinued operations1 | $ | 5,688 | $ | 5,514 | |||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Effective the second quarter of 2026, Quantinuum Inc. (“Quantinuum”) no longer meets the definition of an operating segment, and sales and losses attributable to Quantinuum are excluded from Segment sales and Segment profit, respectively. | |||||||
| 3 | Corporate expenses historically allocated to the Aerospace Technologies and AM businesses and not eligible to be part of discontinued operations are included in Corporate. | |||||||
| Three Months Ended | |||||||||||||||||||||||||||||
| March 31, 2026 | March 31, 2025 | June 30, 2025 | September 30, 2025 | December 31, 2025 | |||||||||||||||||||||||||
| Honeywell Technologies | |||||||||||||||||||||||||||||
| Reported sales % change | 1% | 6% | 7% | —% | 1% | ||||||||||||||||||||||||
| Less: Impact of divestitures to the prior period | (5)% | —% | (3)% | (5)% | (5)% | ||||||||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | 6% | 6% | 10% | 5% | 6% | ||||||||||||||||||||||||
| Less: Foreign currency translation | 2% | (2)% | —% | —% | 1% | ||||||||||||||||||||||||
| Less : Acquisitions | 3% | 6% | 5% | 4% | 3% | ||||||||||||||||||||||||
| Less: Other | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Organic sales % change | 1% | 2% | 5% | 1% | 2% | ||||||||||||||||||||||||
| Building Automation | |||||||||||||||||||||||||||||
| Reported sales % change | 11% | 19% | 16% | 8% | 10% | ||||||||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | 11% | 19% | 16% | 8% | 10% | ||||||||||||||||||||||||
| Less: Foreign currency translation | 3% | (2)% | —% | 1% | 2% | ||||||||||||||||||||||||
| Less : Acquisitions | —% | 13% | 8% | —% | —% | ||||||||||||||||||||||||
| Less: Other | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Organic sales % change | 8% | 8% | 8% | 7% | 8% | ||||||||||||||||||||||||
| Process Automation and Technology | |||||||||||||||||||||||||||||
| Reported sales % change | 5% | 7% | 15% | 8% | 6% | ||||||||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | 5% | 7% | 15% | 8% | 6% | ||||||||||||||||||||||||
| Less: Foreign currency translation | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Less : Acquisitions | 2% | (2)% | 1% | —% | 1% | ||||||||||||||||||||||||
| Less: Other | 9% | 6% | 8% | 14% | 8% | ||||||||||||||||||||||||
| Organic sales % change | (6)% | 3% | 6% | (6)% | (3)% | ||||||||||||||||||||||||
| Industrial Automation | |||||||||||||||||||||||||||||
| Reported sales % change | (11)% | (6)% | (7)% | (14)% | (13)% | ||||||||||||||||||||||||
| Less: Impact of divestitures to the prior period | (15)% | —% | (8)% | (16)% | (15)% | ||||||||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | 4% | (6)% | 1% | 2% | 2% | ||||||||||||||||||||||||
| Less: Foreign currency translation | 3% | (1)% | 1% | 1% | 1% | ||||||||||||||||||||||||
| Less : Acquisitions | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Less: Other | —% | —% | —% | —% | —% | ||||||||||||||||||||||||
| Organic sales % change | 1% | (5)% | —% | 1% | 1% | ||||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||
| March 31, 2024 | June 30, 2024 | September 30, 2024 | December 31, 2024 | ||||||||||||||||||||
| Honeywell Technologies | |||||||||||||||||||||||
| Reported sales % change | (8)% | (4)% | 2% | 7% | |||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | |||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | (8)% | (4)% | 2% | 7% | |||||||||||||||||||
| Less: Foreign currency translation | (1)% | (1)% | —% | (1)% | |||||||||||||||||||
| Less : Acquisitions | 1% | 2% | 4% | 5% | |||||||||||||||||||
| Less: Other | —% | —% | —% | —% | |||||||||||||||||||
| Organic sales % change | (8)% | (5)% | (2)% | 3% | |||||||||||||||||||
| Building Automation | |||||||||||||||||||||||
| Reported sales % change | (4)% | 4% | 14% | 19% | |||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | |||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | (4)% | 4% | 14% | 19% | |||||||||||||||||||
| Less: Foreign currency translation | (1)% | (1)% | —% | —% | |||||||||||||||||||
| Less : Acquisitions | —% | 4% | 11% | 12% | |||||||||||||||||||
| Less: Other | —% | —% | —% | —% | |||||||||||||||||||
| Organic sales % change | (3)% | 1% | 3% | 7% | |||||||||||||||||||
| Process Automation and Technology | |||||||||||||||||||||||
| Reported sales % change | 4% | 4% | 1% | 8% | |||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | |||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | 4% | 4% | 1% | 8% | |||||||||||||||||||
| Less: Foreign currency translation | (1)% | (1)% | (1)% | —% | |||||||||||||||||||
| Less : Acquisitions | 3% | 3% | —% | 4% | |||||||||||||||||||
| Less: Other | —% | —% | —% | —% | |||||||||||||||||||
| Organic sales % change | 2% | 2% | 2% | 4% | |||||||||||||||||||
| Industrial Automation | |||||||||||||||||||||||
| Reported sales % change | (18)% | (15)% | (9)% | (4)% | |||||||||||||||||||
| Less: Impact of divestitures to the prior period | —% | —% | —% | —% | |||||||||||||||||||
| Reported sales percent change, adjusted for impact of divestitures | (18)% | (15)% | (9)% | (4)% | |||||||||||||||||||
| Less: Foreign currency translation | —% | (1)% | —% | (1)% | |||||||||||||||||||
| Less : Acquisitions | —% | —% | —% | —% | |||||||||||||||||||
| Less: Other | —% | —% | —% | —% | |||||||||||||||||||
| Organic sales % change | (18)% | (14)% | (9)% | (3)% | |||||||||||||||||||
| Twelve Months Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Honeywell Technologies | |||||||||||
| Reported sales % change | 3% | (1)% | |||||||||
| Less: Impact of divestitures to the prior period | (3)% | —% | |||||||||
| Reported sales percent change, adjusted for impact of divestitures | 6% | (1)% | |||||||||
| Less: Foreign currency translation | —% | (1)% | |||||||||
| Less : Acquisitions | 4% | 3% | |||||||||
| Less: Other | —% | —% | |||||||||
| Organic sales % change | 2% | (3)% | |||||||||
| Building Automation | |||||||||||
| Reported sales % change | 13% | 8% | |||||||||
| Less: Impact of divestitures to the prior period | —% | —% | |||||||||
| Reported sales percent change, adjusted for impact of divestitures | 13% | 8% | |||||||||
| Less: Foreign currency translation | —% | (1)% | |||||||||
| Less : Acquisitions | 5% | 7% | |||||||||
| Less: Other | —% | —% | |||||||||
| Organic sales % change | 8% | 2% | |||||||||
| Process Automation and Technology | |||||||||||
| Reported sales % change | 9% | 4% | |||||||||
| Less: Impact of divestitures to the prior period | —% | —% | |||||||||
| Reported sales percent change, adjusted for impact of divestitures | 9% | 4% | |||||||||
| Less: Foreign currency translation | —% | (1)% | |||||||||
| Less : Acquisitions | 9% | 2% | |||||||||
| Less: Other | —% | —% | |||||||||
| Organic sales % change | —% | 3% | |||||||||
| Industrial Automation | |||||||||||
| Reported sales % change | (10)% | (12)% | |||||||||
| Less: Impact of divestitures to the prior period | (10)% | —% | |||||||||
| Reported sales percent change, adjusted for impact of divestitures | —% | (12)% | |||||||||
| Less: Foreign currency translation | 1% | (1)% | |||||||||
| Less : Acquisitions | —% | —% | |||||||||
| Less: Other | —% | —% | |||||||||
| Organic sales % change | (1)% | (11)% | |||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| 2026 | 2025 | 2024 | ||||||||||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | |||||||||||||||||||||
| Operating income | $ | 317 | $ | 1,157 | $ | 535 | $ | 1,435 | $ | 516 | $ | 1,344 | ||||||||||||||
Stock compensation expense2 | 42 | 15 | 48 | 13 | 44 | 9 | ||||||||||||||||||||
Repositioning, Other3,4 | 54 | 30 | 43 | 19 | 50 | 42 | ||||||||||||||||||||
Pension and other postretirement service costs4 | 13 | 4 | 9 | 5 | 11 | 5 | ||||||||||||||||||||
Amortization of acquisition-related intangibles5 | 129 | 24 | 116 | 20 | 60 | 10 | ||||||||||||||||||||
Divestiture-related costs2 | 57 | 18 | — | — | — | — | ||||||||||||||||||||
Acquisition-related costs5,6 | — | — | — | — | 3 | — | ||||||||||||||||||||
ERP Implementation costs2 | 6 | — | — | — | — | — | ||||||||||||||||||||
| Impairment of assets held for sale | 263 | — | 15 | — | — | — | ||||||||||||||||||||
Loss on Quantinuum7 | 63 | $ | — | 27 | — | 31 | — | |||||||||||||||||||
| Segment profit | $ | 944 | $ | 1,248 | $ | 793 | $ | 1,492 | $ | 715 | $ | 1,410 | ||||||||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold. | |||||||
| 6 | Includes acquisition-related fair value adjustments to inventory. | |||||||
| 7 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Three Months Ended June 30, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
| Operating income | $ | 666 | $ | 1,448 | $ | 553 | $ | 1,425 | |||||||||
Stock compensation expense2 | 45 | 12 | 45 | 10 | |||||||||||||
Repositioning, Other3,4 | 28 | 26 | 20 | 38 | |||||||||||||
Pension and other postretirement service costs4 | 10 | 5 | 11 | 5 | |||||||||||||
Amortization of acquisition-related intangibles5 | 113 | 20 | 75 | 10 | |||||||||||||
Acquisition-related costs5,6 | (7) | — | 7 | — | |||||||||||||
Loss on Quantinuum7 | 49 | — | 36 | — | |||||||||||||
| Segment profit | $ | 904 | $ | 1,511 | $ | 747 | $ | 1,488 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold. | |||||||
| 6 | Includes acquisition-related fair value adjustments to inventory and third-party transaction and integration costs. | |||||||
| 7 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Three Months Ended September 30, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
| Operating income | $ | 413 | $ | 1,341 | $ | 456 | $ | 1,402 | |||||||||
Stock compensation expense2 | 22 | 14 | 35 | 10 | |||||||||||||
Repositioning, Other3,4 | 224 | 224 | 44 | 25 | |||||||||||||
Pension and other postretirement service costs4 | 14 | 5 | 11 | 5 | |||||||||||||
Amortization of acquisition-related intangibles5 | 135 | 6 | 110 | 10 | |||||||||||||
Acquisition-related costs5,6 | 9 | — | 15 | — | |||||||||||||
Indefinite-lived intangible asset impairment5 | — | — | 48 | — | |||||||||||||
| Impairment of assets held for sale | — | — | 125 | — | |||||||||||||
Loss on Quantinuum7 | 49 | — | 36 | — | |||||||||||||
| Segment profit | $ | 866 | $ | 1,590 | $ | 880 | $ | 1,452 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold. | |||||||
| 6 | Includes acquisition-related fair value adjustments to inventory and third-party transaction and integration costs. | |||||||
| 7 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Three Months Ended December 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
| Operating income | $ | (443) | $ | 1,023 | $ | 648 | $ | 1,097 | |||||||||
Stock compensation expense2 | 38 | 15 | 29 | 12 | |||||||||||||
Repositioning, Other3,4 | 95 | 35 | 33 | 40 | |||||||||||||
Pension and other postretirement service costs4 | 24 | 4 | 13 | 4 | |||||||||||||
Amortization of acquisition-related intangibles5 | 145 | 18 | 129 | 11 | |||||||||||||
Indefinite-lived intangible asset impairment5 | 44 | — | — | — | |||||||||||||
| Impairment of goodwill | 724 | — | — | — | |||||||||||||
| Impairment of assets held for sale | 255 | — | 94 | — | |||||||||||||
Loss on Quantinuum7 | 62 | — | 39 | — | |||||||||||||
| Segment profit | $ | 944 | $ | 1,095 | $ | 985 | $ | 1,164 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold. | |||||||
| 6 | Includes acquisition-related fair value adjustments to inventory and third-party transaction and integration costs. | |||||||
| 7 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
| Operating income | $ | 1,171 | $ | 5,247 | $ | 2,173 | $ | 5,268 | |||||||||
Stock compensation expense2 | 153 | 54 | 153 | 41 | |||||||||||||
Repositioning, Other3,4 | 390 | 304 | 147 | 145 | |||||||||||||
Pension and other postretirement service costs4 | 57 | 19 | 46 | 19 | |||||||||||||
Amortization of acquisition-related intangibles5 | 509 | 64 | 374 | 41 | |||||||||||||
Acquisition-related costs5,6 | 2 | — | 25 | — | |||||||||||||
Indefinite-lived intangible asset impairment5 | 44 | — | 48 | — | |||||||||||||
| Impairment of goodwill | 724 | — | — | — | |||||||||||||
| Impairment of assets held for sale | 270 | — | 219 | — | |||||||||||||
Loss on Quantinuum7 | 187 | — | 142 | — | |||||||||||||
| Segment profit | $ | 3,507 | $ | 5,688 | $ | 3,327 | $ | 5,514 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | Included in Selling, general and administrative expenses. | |||||||
| 3 | Includes repositioning, asbestos, environmental expenses, equity income adjustment, and other charges. | |||||||
| 4 | Included in Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| 5 | Included in Cost of products and services sold. | |||||||
| 6 | Includes acquisition-related fair value adjustments to inventory and third-party transaction and integration costs. | |||||||
| 7 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. Included in Net sales, Cost of products and services sold, Research and development expenses, and Selling, general and administrative expenses. | |||||||
| Three Months Ended March 31, 2026 | ||||||||
| Continuing Operations | Discontinued Operations(1) | |||||||
Earnings per share of common stock - diluted2 | $ | 0.09 | $ | 1.20 | ||||
Pension income3 | (0.10) | (0.09) | ||||||
Amortization of acquisition-related intangibles4 | 0.16 | 0.03 | ||||||
Divestiture-related costs5 | 0.05 | 0.26 | ||||||
Debt restructuring costs6 | 0.35 | — | ||||||
Impairment of assets held for sale7 | 0.31 | — | ||||||
Gain on sale of business8 | (0.01) | — | ||||||
ERP Implementation costs9 | 0.01 | — | ||||||
Loss on Quantinuum10 | 0.03 | — | ||||||
| Adjusted earnings per share of common stock - diluted | $ | 0.89 | $ | 1.40 | ||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the three months ended March 31, 2026, adjusted earnings per share utilizes weighted average shares of approximately 638.4 million. | |||||||
| 3 | For the three months ended March 31, 2026, continuing operations pension income was $65 million, net of tax expense of $20 million. For the three months ended March 31, 2026, discontinued operations pension income was $60 million, net of tax expense of $19 million. | |||||||
| 4 | For the three months ended March 31, 2026, continuing operations acquisition-related intangibles amortization was $99 million, net of tax benefit of $30 million. For the three months ended March 31, 2026, discontinued operations acquisition-related intangibles amortization was $18 million, net of tax benefit of $6 million. | |||||||
| 5 | For the three months ended March 31, 2026, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $29 million as reported, net of tax benefit of approximately $124 million. For the three months ended March 31, 2026, discontinued operations divestiture-related costs was $175 million, net of tax benefit of approximately $25 million. | |||||||
| 6 | For the three months ended March 31, 2026, the adjustment for debt restructuring costs was $226 million, net of tax benefit of $70 million. | |||||||
| 7 | For the three months ended March 31, 2026, the impairment charge of assets held for sale was $200 million, net of tax benefit of $63 million. | |||||||
| 8 | For the three months ended March 31, 2026, the adjustment for gain on sale of the personal protective equipment business was $6 million, without tax benefit. | |||||||
| 9 | For the three months ended March 31, 2026, the adjustment for ERP implementation costs was $5 million, net of tax benefit of $1 million. | |||||||
| 10 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended March 31, 2026, the adjustment for Quantinuum was $17 million, net of tax benefit of $8 million. | |||||||
| Three Months Ended March 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
Earnings per share of common stock - diluted2 | $ | 0.40 | $ | 1.82 | $ | 0.50 | $ | 1.73 | |||||||||
Pension income3 | (0.07) | (0.09) | (0.09) | (0.08) | |||||||||||||
Amortization of acquisition-related intangibles4 | 0.14 | 0.02 | 0.07 | 0.01 | |||||||||||||
Acquisition-related costs5 | 0.01 | — | 0.07 | (0.06) | |||||||||||||
Divestiture-related costs6 | 0.08 | — | — | — | |||||||||||||
Russia-related costs7 | — | — | 0.02 | — | |||||||||||||
Impairment of assets held for sale8 | 0.02 | — | — | — | |||||||||||||
Loss on Quantinuum9 | 0.01 | — | 0.01 | — | |||||||||||||
| Adjusted earnings per share of common stock - diluted | $ | 0.59 | $ | 1.75 | $ | 0.58 | $ | 1.60 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the three months ended March 31, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 651.7 million and 656.6 million. | |||||||
| 3 | For the three months ended March 31, 2025, and 2024, continuing operations pension income was $49 million and $57 million, net of tax expense of $16 million and $17 million, respectively. For the three months ended March 31, 2025, and 2024, discontinued operations pension income was $58 million and $53 million, net of tax expense of $17 million and $18 million, respectively. | |||||||
| 4 | For the three months ended March 31, 2025, and 2024, continuing operations acquisition-related intangibles amortization was $88 million and $50 million, net of tax benefit of $28 million and $10 million, respectively. For the three months ended March 31, 2025, and 2024, discontinued operations acquisition-related intangibles amortization was $15 million and $5 million, net of tax benefit of $5 million and $5 million, respectively. | |||||||
| 5 | For the three months ended March 31, 2025, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs, is $6 million, net of tax benefit of $2 million. For the three months ended March 31, 2024, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs, is $43 million, net of tax expense of $38 million. For the three months ended March 31, 2024, the discontinued operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs, is $39 million, net of tax benefit of $39 million. | |||||||
| 6 | For the three months ended March 31, 2025, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $54 million, net of tax expense of approximately $45 million. | |||||||
| 7 | For the three months ended March 31, 2024, the adjustment is a $17 million expense, without tax benefit, due to the settlement of a contractual dispute with a Russian entity associated with the Company’s suspension and wind down activities in Russia. | |||||||
| 8 | For the three months ended March 31, 2025, the impairment charge of assets held for sale was $15 million, without tax benefit. | |||||||
| 9 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended March 31, 2025 and 2024, the adjustment for Quantinuum was $8 million and $8 million, net of tax benefit of $4 million and $4 million, respectively. | |||||||
| Three Months Ended June 30, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
Earnings per share of common stock - diluted2 | $ | 0.60 | $ | 1.85 | $ | 0.54 | $ | 1.82 | |||||||||
Pension income3 | (0.01) | (0.09) | (0.08) | (0.08) | |||||||||||||
Amortization of acquisition-related intangibles4 | 0.13 | 0.03 | 0.09 | 0.01 | |||||||||||||
Acquisition-related costs5 | — | — | 0.09 | (0.06) | |||||||||||||
Divestiture-related costs6 | 0.09 | 0.01 | — | — | |||||||||||||
Loss (gain) on sale of business7 | 0.04 | — | — | — | |||||||||||||
Loss on Quantinuum8 | 0.03 | — | 0.02 | — | |||||||||||||
| Adjusted earnings per share of common stock - diluted | $ | 0.88 | $ | 1.80 | $ | 0.66 | $ | 1.69 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the three months ended June 30, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 640.9 million and 654.2 million. | |||||||
| 3 | For the three months ended June 30, 2025, and 2024, continuing operations pension income was $7 million and $52 million, net of tax expense of $3 million and $15 million, respectively. For the three months ended June 30, 2025, and 2024, discontinued operations pension income was $58 million and $55 million, net of tax expense of $17 million and $18 million, respectively. | |||||||
| 4 | For the three months ended June 30, 2025, and 2024, continuing operations acquisition-related intangibles amortization was $86 million and $58 million, net of tax benefit of $27 million and $17 million, respectively. For the three months ended June 30, 2025, and 2024, discontinued operations acquisition-related intangibles amortization was $15 million and $8 million, net of tax benefit of $5 million and $2 million, respectively. | |||||||
| 5 | For the three months ended June 30, 2024, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $62 million, net of tax expense of $34 million. For the three months ended June 30, 2024, the discontinued operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $40 million, net of tax benefit of $41 million. | |||||||
| 6 | For the three months ended June 30, 2025, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $54 million, net of tax expense of approximately $14 million. For the three months ended June 30, 2025, discontinued operations divestiture-related costs was $8 million, net of tax benefit of approximately $33 million. | |||||||
| 7 | For the three months ended June 30, 2025, the adjustment for loss on sale of the personal protective equipment business was $28 million, net of tax benefit of $2 million. | |||||||
| 8 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended June 30, 2025 and 2024, the adjustment for Quantinuum was $16 million and $11 million, net of tax benefit of $7 million and $5 million, respectively. | |||||||
| Three Months Ended September 30, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
Earnings per share of common stock - diluted2 | $ | 1.50 | $ | 1.36 | $ | 0.37 | $ | 1.79 | |||||||||
Pension income3 | (0.09) | (0.09) | (0.09) | (0.08) | |||||||||||||
Amortization of acquisition-related intangibles4 | 0.16 | 0.01 | 0.13 | 0.01 | |||||||||||||
Acquisition-related costs5 | 0.03 | — | 0.07 | (0.04) | |||||||||||||
Divestiture-related costs6 | 0.28 | 0.32 | — | — | |||||||||||||
Indefinite-lived intangible asset impairment7 | — | — | 0.06 | — | |||||||||||||
Impairment of assets held for sale8 | — | — | 0.19 | — | |||||||||||||
Gain related to Resideo indemnification and reimbursement agreement termination9 | (1.26) | — | — | — | |||||||||||||
Adjustment to estimated future environmental liabilities10 | 0.03 | 0.22 | — | — | |||||||||||||
Loss on settlement of divestiture of asbestos liabilities11 | 0.17 | — | — | — | |||||||||||||
Loss on Quantinuum12 | 0.02 | — | 0.02 | — | |||||||||||||
| Adjusted earnings per share of common stock - diluted | $ | 0.84 | $ | 1.82 | $ | 0.75 | $ | 1.68 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the three months ended September 30, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 638.8 million and 654.1 million. | |||||||
| 3 | For the three months ended September 30, 2025, and 2024, continuing operations pension income was $57 million and $58 million, net of tax expense of $18 million and $19 million, respectively. For the three months ended September 30, 2025, and 2024, discontinued operations pension income was $57 million and $52 million, net of tax expense of $17 million and $16 million, respectively. | |||||||
| 4 | For the three months ended September 30, 2025, and 2024, continuing operations acquisition-related intangibles amortization was $102 million and $87 million, net of tax benefit of $33 million and $23 million, respectively. For the three months ended September 30, 2025, and 2024, discontinued operations acquisition-related intangibles amortization was $5 million and $8 million, net of tax benefit of $1 million and $2 million, respectively. | |||||||
| 5 | For the three months ended September 30, 2025, and 2024, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $17 million and $47 million, net of tax benefit of $5 million, and net of tax expense of $23 million. For the three months ended September 30, 2024, the discontinued operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $27 million, net of tax benefit of $28 million. | |||||||
| 6 | For the three months ended September 30, 2025, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $180 million, net of tax expense of approximately $122 million. For the three months ended September 30, 2025, discontinued operations divestiture-related costs was $202 million, net of tax benefit of approximately $7 million. | |||||||
| 7 | For the three months ended September 30 2024, the impairment charge of indefinite-lived intangible assets associated with the personal protective equipment business was $37 million, net of tax benefit of $11 million. | |||||||
| 8 | For the three months ended September 30, 2024, the impairment charge of assets held for sale was $125 million, without tax benefit. | |||||||
| 9 | For the three months ended September 30, 2025, the gain related to the Resideo indemnification and reimbursement agreement termination was $802 million, without tax expense. | |||||||
| 10 | In the three months ended September 30, 2025, the Company enhanced its process for estimating environmental liabilities at sites undergoing active remediation, which led to earlier recognition of the estimated probable liabilities and an increase to estimated environmental liabilities. For the three months ended September 30, 2025, the continuing operations adjustment to increase environmental liabilities was $22 million, net of tax benefit of $7 million. For the twelve months ended December 31, 2025, the discontinued operations adjustment to increase environmental liabilities was $139 million, net of tax benefit $43 million. | |||||||
| 11 | For the three months ended September 30, 2025, the adjustment for loss on settlement of divestiture of asbestos liabilities was $112 million, net of tax benefit of $36 million. | |||||||
| 12 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended September 30, 2025 and 2024, the adjustment for Quantinuum was $16 million and $10 million, net of tax benefit of $6 million and $5 million, respectively. | |||||||
| Three Months Ended December 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
Earnings per share of common stock - diluted2 | $ | (0.88) | $ | 0.70 | $ | 0.58 | $ | 1.38 | |||||||||
Pension expense (income)3 | 0.11 | (0.12) | 0.04 | (0.08) | |||||||||||||
Amortization of acquisition-related intangibles4 | 0.17 | 0.02 | 0.15 | 0.01 | |||||||||||||
Acquisition-related costs5 | 0.02 | — | 0.09 | (0.07) | |||||||||||||
Divestiture-related costs6 | (0.04) | 0.53 | — | 0.04 | |||||||||||||
Indefinite-lived intangible asset impairment7 | 0.07 | — | — | — | |||||||||||||
Impairment of goodwill8 | 1.13 | — | — | — | |||||||||||||
Impairment of assets held for sale9 | 0.31 | — | 0.14 | — | |||||||||||||
Flexjet-related litigation matters10 | — | 0.47 | — | — | |||||||||||||
Loss on Quantinuum11 | 0.03 | — | 0.02 | — | |||||||||||||
| Adjusted earnings per share of common stock - diluted | $ | 0.92 | $ | 1.60 | $ | 1.02 | $ | 1.28 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the three months ended December 31, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 638.6 million and 654.8 million. | |||||||
| 3 | For the three months ended December 31, 2025, and 2024, continuing operations pension expense was $73 million and $26 million, net of tax benefit of $12 million and $7 million, respectively. For the three months ended December 31, 2025, and 2024, discontinued operations pension income was $79 million and $55 million, net of tax expense of $13 million and $14 million, respectively. | |||||||
| 4 | For the three months ended December 31, 2025, and 2024, continuing operations acquisition-related intangibles amortization was $110 million and $97 million, net of tax benefit of $35 million and $32 million, respectively. For the three months ended December 31, 2025, and 2024, discontinued operations acquisition-related intangibles amortization was $14 million, net of tax benefit of $4 million, and $11 million, without tax benefit, respectively. | |||||||
| 5 | For the three months ended December 31, 2025, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $13 million, net of tax benefit of $4 million. For the three months ended December 31, 2024, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $61 million, net of tax expense of $47 million. For the three months ended December 31, 2024, the discontinued operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $48 million, net of tax benefit of $50 million. | |||||||
| 6 | For the three months ended December 31, 2025, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $27 million, net of tax benefit of approximately $150 million. For the three months ended December 31, 2025, discontinued operations divestiture-related costs was $341 million, net of tax expense of approximately $138 million. | |||||||
| 7 | For the three months ended December 31, 2025, the impairment charge of assets held for sale was $44 million, without tax benefit. | |||||||
| 8 | For the three months ended December 31, 2025, the impairment charge of goodwill associated with the Industrial Automation reportable segment was $724 million, without tax benefit. | |||||||
| 9 | For the three months ended December 31, 2025, the impairment charge of assets held for sale was $194 million, net of tax benefit of $61 million. For the three months ended December 31, 2024, the impairment charge of assets held for sale was $94 million, without tax benefit. | |||||||
| 10 | For the three months ended December 31, 2025, the adjustment for the Flexjet-related litigation matters was $302 million, net of tax benefit of $71 million. Management considers the nature and significance of these litigation matters to be unusual and not indicative of the Company's ongoing performance. | |||||||
| 11 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the three months ended December 31, 2025 and 2024, the adjustment for Quantinuum was $18 million and $12 million, net of tax expense of $8 million and $6 million, respectively. | |||||||
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Continuing Operations | Discontinued Operations1 | Continuing Operations | Discontinued Operations1 | ||||||||||||||
Earnings per share of common stock - diluted2 | $ | 1.62 | $ | 5.74 | $ | 1.99 | $ | 6.72 | |||||||||
Pension income3 | (0.06) | (0.39) | (0.22) | (0.33) | |||||||||||||
Amortization of acquisition-related intangibles4 | 0.60 | 0.08 | 0.45 | 0.04 | |||||||||||||
Acquisition-related costs5 | 0.05 | — | 0.32 | (0.23) | |||||||||||||
Divestiture-related costs6 | 0.41 | 0.85 | — | 0.04 | |||||||||||||
Russia related-charges7 | — | — | 0.03 | — | |||||||||||||
Indefinite-lived intangible asset impairment8 | 0.07 | — | 0.06 | — | |||||||||||||
Impairment of Goodwill9 | 1.13 | — | — | — | |||||||||||||
Impairment of assets held for sale10 | 0.33 | — | 0.33 | — | |||||||||||||
Loss on sale of business11 | 0.04 | — | — | — | |||||||||||||
Gain related to Resideo indemnification and reimbursement agreement termination12 | (1.25) | — | — | — | |||||||||||||
Adjustment to estimated future environmental liabilities13 | 0.03 | 0.22 | — | — | |||||||||||||
Loss on expected settlement of divestiture of asbestos liabilities14 | 0.17 | — | — | — | |||||||||||||
Flexjet-related litigation matters15 | — | 0.47 | — | — | |||||||||||||
Loss on Quantinuum16 | 0.09 | — | 0.06 | — | |||||||||||||
| Adjusted earnings per share of common stock - diluted | $ | 3.23 | $ | 6.97 | $ | 3.02 | $ | 6.24 | |||||||||
| 1 | Effective June 29, 2026, Honeywell International Inc. rebranded as Honeywell Technologies and completed the spin-off of its Aerospace Technologies business into an independent publicly traded company, Honeywell Aerospace Inc. In connection with the spin-off, the Aerospace Technologies business is reported as discontinued operations in all periods presented. Additionally, discontinued operations includes the results of the Advanced Materials (“AM”) business, which was spun-off into an independent, publicly traded company, Solstice Advanced Materials, on October 30, 2025. The AM business was previously presented as discontinued operations effective the fourth quarter of 2025. | |||||||
| 2 | For the twelve months ended December 31, 2025, and 2024, adjusted earnings per share utilizes weighted average shares of approximately 642.8 million and 655.3 million. | |||||||
| 3 | For the twelve months ended December 31, 2025, and 2024, continuing operations pension income was $40 million and $141 million, net of tax expense of $25 million and $44 million, respectively. For the twelve months ended December 31, 2025, and 2024, discontinued operations pension income was $252 million and $215 million, net of tax expense of $64 million and $66 million, respectively. | |||||||
| 4 | For the twelve months ended December 31, 2025, and 2024, continuing operations acquisition-related intangibles amortization was $386 million and $292 million, net of tax benefit of $123 million and $82 million, respectively. For the twelve months ended December 31, 2025, and 2024, discontinued operations acquisition-related intangibles amortization was $49 million and $32 million, net of tax benefit of $15 million and $9 million, respectively. | |||||||
| 5 | For the twelve months ended December 31, 2025, the continuing operations adjustment for acquisition-related costs, which is principally comprised of third-party transaction and integration costs and acquisition-related fair value adjustments to inventory, is $35 million, net of tax benefit of $10 million. For the twelve months ended December 31, 2024, the continued operations adjustment for acquisition-related costs is $213 million, net of tax expense of $142 million. For the twelve months ended December 31, 2024, the discontinued operations adjustment for acquisition-related costs is $154 million, net of tax benefit of $158 million. | |||||||
| 6 | For the twelve months ended December 31, 2025, the continuing operations adjustment for divestiture-related costs, which is principally comprised of third-party transaction costs, was $262 million, net of tax benefit of approximately $31 million. For the twelve months ended December 31, 2025, discontinued operations divestiture-related costs was $548 million, net of tax expense of approximately $56 million. | |||||||
| 7 | For the twelve months ended December 31, 2024, the adjustment is a $17 million expense, without tax benefit, due to the settlement of a contractual dispute with a Russian entity associated with the Company’s suspension and wind down activities in Russia. | |||||||
| 8 | For the twelve months ended December 31, 2025, the impairment charge of indefinite-lived intangible assets associated with the Industrial Automation reportable segment was $44 million, without tax benefit. For the twelve months ended December 31, 2024, the impairment charge of indefinite-lived intangible assets associated with the personal protective equipment business was $37 million, net of tax benefit of $11 million. | |||||||
| 9 | For the twelve months ended December 31, 2025, the impairment charge of goodwill associated with the Industrial Automation reportable segment was $724 million, without tax benefit. | |||||||
| 10 | For the twelve months ended December 31, 2025, the impairment charge of assets held for sale was $209 million, net of tax benefit of $61 million.For the twelve months ended December 31, 2024, the impairment charge of assets held for sale was $219 million, without tax benefit. | |||||||
| 11 | For the twelve months ended December 31, 2025, the adjustment for loss on sale of the personal protective equipment business was $28 million, net of tax benefit of $2 million. | |||||||
| 12 | For the twelve months ended December 31, 2025, the gain related to the Resideo indemnification and reimbursement agreement termination was $802 million, without tax expense. | |||||||
| 13 | In the twelve months ended December 31, 2025, the Company enhanced its process for estimating environmental liabilities at sites undergoing active remediation, which led to earlier recognition of the estimated probable liabilities and an increase to estimated environmental liabilities. For the twelve months ended December 31, 2025, the continuing operations adjustment to increase environmental liabilities was $22 million, net of tax benefit of $7 million. For the twelve months ended December 31, 2025, the discontinued operations adjustment to increase environmental liabilities was $139 million, net of tax benefit $43 million. | |||||||
| 14 | For the twelve months ended December 31, 2025, the adjustment for loss on settlement of divestiture of asbestos liabilities was $112 million, net of tax benefit of $36 million. | |||||||
| 15 | For the twelve months ended December 31, 2025, the adjustment for the Flexjet-related litigation matters was $302 million, net of tax benefit of $71 million. Management considers the nature and significance of these litigation matters to be unusual and not indicative of the Company's ongoing performance. | |||||||
| 16 | Includes losses attributable to the Company’s investment in Quantinuum, which does not meet the definition of an operating segment. For the twelve months ended December 31, 2025 and 2024, the adjustment for Quantinuum was $58 million and $41 million, net of tax benefit of $25 million and $20 million, respectively. | |||||||